Comparison Overview

Prospect News

VS

Pharmanews Limited

Prospect News

6 Maiden Lane, 9th Floor, New York, NY, 10038, US
Last Update: 2025-11-25
Between 750 and 799

Prospect News publishes 14 daily and three weekly newsletters covering corporate, municipal and sovereign bond and debt markets. Each publication focuses exclusively on an individual market segment, giving finance professionals and investors all the information they need. The newsletters comprehensively cover new issue terms, tenders and redemptions, ratings, upcoming calendar events, and defaults, and provide plenty of market color each trading day. Visit our website to see samples of our daily newsletters, sign up for free trials, search our extensive database of past news reports, and look up terms on deals or analyze issuance trends. http://www.prospectnews.com Email us at [email protected]

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 13
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Pharmanews Limited

8, Akinwunmi Street, Mende, Maryland,, Lagos, Lagos state +234, NG
Last Update: 2025-11-28
Between 750 and 799

Pharmanews Limited was established in 1979 as publishers of health periodicals with Pharmanews as the leading journal. From 1993, the training arm of the company commenced and has since become reputable trainers of health personnel and institutions nationwide. We also engage in consultancy and book publishing. We remain committed to this vision by delivering qualitative services based on integrity. Published every month since its inception in 1979, Pharmanews is a professional health journal targeted primarily at healthcare providers. It is the largest circulating periodical covering all the 36 states of Nigeria and Abuja. It also circulates in Anglophone West Africa. It continues to break new grounds in health reporting and has established an enviable reputation in the health care profession and in the pharmaceutical industry, in particular. Money spent on adverts is guaranteed, as Pharmanews provides information on advertisers'​ products and services to health policy/decision makers. It also supports advertisers through providing promotional services. Our watchword is constant and never-ending improvement.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 23
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/prospect-news.jpeg
Prospect News
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/pharmanews-limited.jpeg
Pharmanews Limited
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Prospect News
100%
Compliance Rate
0/4 Standards Verified
Pharmanews Limited
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Prospect News in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Pharmanews Limited in 2025.

Incident History — Prospect News (X = Date, Y = Severity)

Prospect News cyber incidents detection timeline including parent company and subsidiaries

Incident History — Pharmanews Limited (X = Date, Y = Severity)

Pharmanews Limited cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/prospect-news.jpeg
Prospect News
Incidents

No Incident

https://images.rankiteo.com/companyimages/pharmanews-limited.jpeg
Pharmanews Limited
Incidents

No Incident

FAQ

Prospect News company demonstrates a stronger AI Cybersecurity Score compared to Pharmanews Limited company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Pharmanews Limited company has disclosed a higher number of cyber incidents compared to Prospect News company.

In the current year, Pharmanews Limited company and Prospect News company have not reported any cyber incidents.

Neither Pharmanews Limited company nor Prospect News company has reported experiencing a ransomware attack publicly.

Neither Pharmanews Limited company nor Prospect News company has reported experiencing a data breach publicly.

Neither Pharmanews Limited company nor Prospect News company has reported experiencing targeted cyberattacks publicly.

Neither Prospect News company nor Pharmanews Limited company has reported experiencing or disclosing vulnerabilities publicly.

Neither Prospect News nor Pharmanews Limited holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Prospect News company nor Pharmanews Limited company has publicly disclosed detailed information about the number of their subsidiaries.

Pharmanews Limited company employs more people globally than Prospect News company, reflecting its scale as a Book and Periodical Publishing.

Neither Prospect News nor Pharmanews Limited holds SOC 2 Type 1 certification.

Neither Prospect News nor Pharmanews Limited holds SOC 2 Type 2 certification.

Neither Prospect News nor Pharmanews Limited holds ISO 27001 certification.

Neither Prospect News nor Pharmanews Limited holds PCI DSS certification.

Neither Prospect News nor Pharmanews Limited holds HIPAA certification.

Neither Prospect News nor Pharmanews Limited holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.